期刊文献+

COX-1在宫颈恶性肿瘤组织中的表达及其意义 被引量:3

Expression of cyclooxygenase-1 in cervical carcinoma and its significance
暂未订购
导出
摘要 目的探讨环氧化酶-1(COX-1)在宫颈恶性肿瘤组织中的表达及其临床意义。方法收集1999年1月-2005年3月在解放军307医院行手术或活检的62例患者的组织标本,包括31例宫颈癌、15例宫颈上皮内瘤变、16例正常宫颈组织,应用免疫组化SP法检测3种组织中COX-1蛋白的表达差异,并分析COX-1蛋白与患者临床病理特征间的相关性。结果COX-1蛋白主要在细胞质中表达,其次在细胞膜上表达。COX-1蛋白在宫颈癌中呈强阳性表达,在宫颈上皮内瘤变中呈弱阳性表达,表达率分别为81%和13%,差异有统计学意义(P<0.01),而在正常宫颈组织中未见明显阳性表达。COX-1的表达与肿瘤分化程度、临床分期及患者年龄无明显相关性(P>0.05)。结论COX-1蛋白表达可作为宫颈癌的诊断、治疗选择及判断预后的辅助指标。 Objective To explore the expression of cyclooxygenase-1 (COX-1) in cervical carcinoma and its significance. Methods The pathological specimens were collected from 62 female patients, who were admitted to 307 Hospital of PLA from Jan. 1999 to Mar. 2005, including 31 cases of cervical carcinomas, 15 cases of cervical intraepithelial neoplasia and 16 cases of normal cervix. Surgery or biopsy was performed. Expression of COX-1 was detected by immunohistochemistry, and the relationship between COX-1 and clinicopathological feature was analyzed. Results The major sites of COX-1 expression were localized in cytoplasm, and next in cell membrane. Strongly positive expression of COX-1 was observed in cervical carcinomas, and weakly positive expression of COX-1 in cervical intra-epithelial neoplasia, with positive rates of 81% and 13%, respectively. There was no COX-1 expression in normal cervix. A significant difference was observed among these specimens. No obvious correlation was found between COX-1 expression and patient's age, tumor differentiation degree snd clinical stages. Conclusion Expression of COX-1 may serve as an auxiliary parameter for diagnosis, therapeutic scheme option, and prognosis of patients with cervical carcinoma.
出处 《解放军医学杂志》 CAS CSCD 北大核心 2010年第5期573-575,共3页 Medical Journal of Chinese People's Liberation Army
关键词 环氧化酶1 宫颈肿瘤 宫颈上皮内瘤样病变 cyclooxygenase 1 uterine cervical neoplasms cervical intraepithelial neoplasia
  • 相关文献

参考文献13

  • 1程鸾,李亚里,李春海.新的卵巢癌标志物COX-1的临床评价[J].解放军医学杂志,2002,27(9):839-840. 被引量:2
  • 2吴琼,佟雅丽,黄长江,李春海,卞丽红,向军琳.环氧化酶-1在妇科恶性肿瘤诊断中的作用研究[J].中国妇产科临床杂志,2003,4(5):373-375. 被引量:2
  • 3Miller RC, Lanasa P, Hanson WR, et al. Misoprostol: a potent cytotoxic and oncogenic radioprotector[J]. Adv Exp Med Biol, 1997, 400B: 861-864.
  • 4Lee CY, Chen KW, Sheu FS, el al. Studies of a tumor-associated antigen, COX-1, recognized by a monoclonal antibody[J]. Cancer Immunol Immunother, 1992, 35(1):19-26.
  • 5Li S, Miner K, Fannin R, et al. Cyclooxygenase-1 and 2 in normal and malignant human ovarian epithelium[J]. Gynecol Oncol, 2004, 92(2): 622-627.
  • 6Church R, Yu J, Fleshman J, et al. RNA profiling of cyclooxygenases 1 and 2 in eolorectal cancer[J]. Br J Cancer, 2004, 91(6): 1015-1018.
  • 7von Rahden B, Stein H, Puhringer F, et al. Coexpression of cydooxygenases (COX-1, COX-2) and vascular endothdial growth factors (VEGF-A, VEGF-C) in esophageal adenocardnoma[J]. Cancer Res, 2005, 65(12)= 5038-5044.
  • 8Daikoku T, Wang D, Tranguch S, et al.Cyclooxygenase-1 is a potential target for prevention and treatment of ovarian epithelial cancer [J]. Cancer Res, 2005, 65(9): 3735-3744.
  • 9Sales K, Katz A, Howard B, et al. Cyclooxygenase-1 is up-regulated in cervical carcinomas: autocrine/paracrine regulation of cyclooxygenase-2, prostaglandin e receptors, and angiogenic factors by cyclooxygenase-1[J]. Cancer Res, 2002, 62(2): 424-432.
  • 10Athavale R, Clooney K, OHagan J, et al. COX-1 and COX-2 expression in stage I and II invasive cervical carcinoma: relationship to disease relapse and long-term survival[J]. Int J Gynecol Cancer, 2006, 16(3): 1303-1308.

二级参考文献11

  • 1[1]Schwartz PE, Taylor KJ. Is early detection of ovarian cancer possible? J Ann Med, 1995, 27: 519-523.
  • 2[2]Turnheim K. Coxibe: Hemmer der Cyclooxygenase - 2. Wien Klin Wochenschr, 2001, 113: 558-565.
  • 3[3]Lee G, Ng HT. Clinical evaluations of a new ovarian cancer marker,COX- 1. Int J Gynaecol Obstet, 1995, 49 (Suppl): S27-32.
  • 4[4]Kirschenbaum A, Klausner AP, Lee R, et al. Expression of cyclooxygenase- 1 and cyclooxygenase - 2 in the human prostate. Urology,2000, 56: 671-676.
  • 5[5]Khan KN, Knapp DW, Denicola DB, et al. Expression of cyclooxygenase - 2 in transitional cell carcinoma of the urinary bladder in dog. AmJ Vet Res, 2000, 61: 478-481.
  • 6[6]Bauer AK, Dwyer- Nield LD, Malkinson AM. High cyclooxygenase 1(COX - 1 ) and cyclooxygenase 2 (COX - 2) contents in mouse lung tumors. Carcinogenesis, 2000, 21: 543-550.
  • 7[7]Williams CS, Mann M, DuBois RN. The role of cyclooxygenases in inflammation, cancer and development. Oncogene, 1999, 18: 7908-7916.
  • 8[10]Geary GG, McNeill AM, Ospina JA, et al. Selected contribution:cerebrovascular nos and cyclooxygenase are unaffected by estrogen in mice lacking estrogen receptor- alpha. J Appl Physiol, 2001, 91:2391 -2399.
  • 9[11]Wong E, Bayly C, Waterman HL, et al. Conversion of prostaglandin G/H synthase - 1 into an enzyme senitive to PGHS- 2selective inhibitors by a double His513 to Arg and Ile523 to Val mutation. J Biol Chem,1997, 272: 9280-9286.
  • 10李云,王蔼明,张志文.环加氧酶和前列腺素E受体亚型基因在人卵巢的表达[J].北京医科大学学报,1998,30(3):207-209. 被引量:6

共引文献2

同被引文献47

引证文献3

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部